These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21181185)

  • 1. Magnetic resonance imaging in progressive supranuclear palsy.
    Stamelou M; Knake S; Oertel WH; Höglinger GU
    J Neurol; 2011 Apr; 258(4):549-58. PubMed ID: 21181185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced structural neuroimaging in progressive supranuclear palsy: Where do we stand?
    Stezin A; Lenka A; Jhunjhunwala K; Saini J; Pal PK
    Parkinsonism Relat Disord; 2017 Mar; 36():19-32. PubMed ID: 28057431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
    Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-Brain Magnetic Resonance Spectroscopy Reveals Distinct Alterations in Neurometabolic Profile in Progressive Supranuclear Palsy.
    Klietz M; Mahmoudi N; Maudsley AA; Sheriff S; Bronzlik P; Almohammad M; Nösel P; Wegner F; Höglinger GU; Lanfermann H; Ding XQ
    Mov Disord; 2023 Aug; 38(8):1503-1514. PubMed ID: 37289057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.
    Bacchi S; Chim I; Patel S
    J Med Imaging Radiat Oncol; 2018 Feb; 62(1):21-31. PubMed ID: 28432758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism.
    Agosta F; Pievani M; Svetel M; Ječmenica Lukić M; Copetti M; Tomić A; Scarale A; Longoni G; Comi G; Kostić VS; Filippi M
    Neurobiol Aging; 2012 Dec; 33(12):2817-26. PubMed ID: 22418735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy.
    Canu E; Agosta F; Baglio F; Galantucci S; Nemni R; Filippi M
    Mov Disord; 2011 Aug; 26(9):1752-5. PubMed ID: 21500281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls.
    Focke NK; Helms G; Scheewe S; Pantel PM; Bachmann CG; Dechent P; Ebentheuer J; Mohr A; Paulus W; Trenkwalder C
    Hum Brain Mapp; 2011 Nov; 32(11):1905-15. PubMed ID: 21246668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease.
    Morelli M; Arabia G; Salsone M; Novellino F; Giofrè L; Paletta R; Messina D; Nicoletti G; Condino F; Gallo O; Lanza P; Quattrone A
    Mov Disord; 2011 Feb; 26(3):527-33. PubMed ID: 21287599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.
    Seppi K; Poewe W
    Neuroimaging Clin N Am; 2010 Feb; 20(1):29-55. PubMed ID: 19959017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy.
    Cherubini A; Morelli M; Nisticó R; Salsone M; Arabia G; Vasta R; Augimeri A; Caligiuri ME; Quattrone A
    Mov Disord; 2014 Feb; 29(2):266-9. PubMed ID: 24323617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.